Introduction {#s1}
============

Transmissible spongiform encephalopathies (TSEs), or prion diseases, are fatal neurodegenerative diseases that affect a variety of species, including humans (Kuru; variant Creutzfeldt-Jakob disease \[vCJD\]), cattle (bovine spongiform encephalopathy \[BSE\]), sheep (scrapie), mink (transmissible mink encephalopathy \[TME\]), domestic and nondomestic cats (feline spongiform encephalopathy \[FSE\]) and cervids (chronic wasting disease \[CWD\]).

The transmission of prions, while remaining poorly understood, has obvious public health significance and requires sustained re-appraisal of present concepts for both TSE spread and intervention strategies. It is clear that TSEs are spread by horizontal means of transmission via oral ingestion (Kuru, BSE, vCJD, TME, FSE, CWD) and environmental (scrapie, CWD) contact with infectious prions, as well as by medical means including blood transfusion (vCJD, CWD, scrapie), or iatrogenic exposure (vCJD, sCJD). While less studied, supporting evidence has emerged for an additional path of transmission-- that from mother to offspring.

A variant form of the human prion disease CJD, known as variant CJD (vCJD), was attributed to the ingestion of BSE-infected meat products [@pone.0071844-Ironside1], [@pone.0071844-Lasmzas1]. It is known that vCJD can be transmitted from human to human via blood transfusion from both symptomatic and asymptomatic donors [@pone.0071844-Llewelyn1]--[@pone.0071844-Team1] and that a prolonged asymptomatic incubation period occurs in 129 Met/Val individuals [@pone.0071844-Goldfarb1]. It is estimated that up to 1 in 4,000 individuals in the UK are asymptomatic carriers of vCJD [@pone.0071844-Clewley1]--[@pone.0071844-Clarke1].

To date, 125 children have been born to women who later developed CJD [@pone.0071844-Murray1]. This is concerning because PrP^CJD^ has been detected in the fetal and pregnancy related tissues of a woman infected with CJD [@pone.0071844-Tamai1]. Although decades may pass before the onset of clinical effects associated with such transmission due to a long subclinical carrier state, the probability that these individuals harbor infectious prions remains high.

Animal TSEs suggest similar disease patterns. Scrapie prions have been detected in maternal and fetal sheep tissues [@pone.0071844-Race1]--[@pone.0071844-Garza1], and there is a higher incidence of clinical disease during the lambing season [@pone.0071844-Caplazi1], [@pone.0071844-Dickinson1]--[@pone.0071844-Brotherston1]. It is known that BSE incidence is higher in calves born to BSE-infected cattle [@pone.0071844-BrugrePicoux1], [@pone.0071844-Braun1] and that BSE has been transmitted to the offspring of BSE-infected female mice expressing bovid PrP [@pone.0071844-Castilla1]. A cheetah cub, born to a FSE-infected cheetah, was housed in a TSE-free environment and fed a TSE-free diet, yet succumbed to FSE at 7 years of age [@pone.0071844-Bencsik1], suggesting maternal exposure.

Importantly, infectious prions are present in the brain, bodily fluids and excreta of animals showing no clinical signs of TSE [@pone.0071844-Haley1]--[@pone.0071844-Sa1]. For example, the blood, saliva and urine from deer subclinically infected with CWD contain infectious prions [@pone.0071844-Haley1], [@pone.0071844-Mathiason1], [@pone.0071844-Mathiason2]. Race and coworkers [@pone.0071844-Race2] found a long-term subclinical carrier state in mice infected with hamster scrapie. Atypical BSE (BASE) can be transmitted from non-clinical cattle to primates [@pone.0071844-Comoy1] and cattle exposed to large oral doses of BSE can remain free of clinical signs but are found to harbor infectious prions upon bioassay into bovid PrP transgenic mice [@pone.0071844-Espinosa1]. Taken together, these findings suggest that carriers without clinical signs exist and may transmit infection to their offspring via milk, transplacental trafficking or blood.

Chronic wasting disease, known for its efficient transmission among cervids, is now recognized in 22 states, two Canadian provinces and South Korea (<http://www.nwhc.usgs.gov/disease_information/chronic_wasting_disease/index.jsp>). Studies proved that CWD can be horizontally transmitted among cervids either by direct contact with infected animals [@pone.0071844-Miller1], their secreta [@pone.0071844-Haley1], [@pone.0071844-Safar1], [@pone.0071844-Mathiason1], [@pone.0071844-Tamgney1] or indirectly through the environment they inhabit [@pone.0071844-Mathiason2], [@pone.0071844-Saunders1]. As observed in other animal TSEs, even cervids in the subclinical phase of disease harbor transmissible infectious prions [@pone.0071844-Haley1], [@pone.0071844-Mathiason2], [@pone.0071844-Houston1]--[@pone.0071844-Sis1]. Although there is a growing body of evidence that identifies the sources of infectious prions, less defined are the mechanisms by which prions are shed by infected hosts and taken up by their naïve counterparts. One such mechanism may include that from mother to offspring, either *in utero* (vertical transmission), or shortly after birth in colostrum or milk (maternal transmission).

To address the possibility of CWD mother to offspring transmission we utilized Reeves' muntjac deer (*Muntiacus reevesi*) [@pone.0071844-Wilson1]. This small Asian deer reaches sexual maturity at 6 months of age, is polyestrous, and can be bred and housed conveniently in indoor controlled laboratory conditions, thus providing a suitable *in vivo* model for cervid vertical/maternal transmission studies [@pone.0071844-Chapman1].

We undertook this study to determine: 1) whether Reeves' muntjac deer are susceptible to CWD, 2) whether CWD is transmitted from mother to offspring, and 3) whether offspring born to CWD-infected mothers develop clinical TSE disease.

Materials and Methods {#s2}
=====================

Muntjac Source {#s2a}
--------------

All breeding age male and female muntjac were provided by and transported to Colorado State University by Cervid Solutions Inc., Tellico TN. All animals were handled in strict accordance with guidelines for animal care and use provided by the United States Department of Agriculture (USDA), National Institutes of Health (NIH) and the Association for Assessment and Accreditation of Laboratory Animal Care International (AAALAC), and all animal work was approved by Colorado State University Institutional Animal Care and Use Committee (IACUC approval numbers 02-151A, 08-175A and 11-2615A).

Genotyping {#s2b}
----------

All muntjac dams, fawns and fetuses were genotyped to determine the PRNP coding sequence in the laboratory of Dr. Wilfred Goldmann, The Roslin Institute, University of Edinburgh, Scotland, U.K. DNA amplification and sequencing reactions were performed as described in Hunter et al. [@pone.0071844-Hunter2], but using deer specific PCR primer pair 213d AGGTCAACTTTGTCCTTGGAGGAG and 139u TAAGCGCCAAGGGTATTAGCAT and sequencing primers 86 d CAGTCATTCATTATGCTGCAGACT or 70 u GCTGCAGGTAGATACTCCCTC.

Biocontainment Protocols {#s2c}
------------------------

Protocols to preclude extraneous exposure and cross-contamination between cohorts of animals as previously described [@pone.0071844-Mathiason1] incorporated protective shower-in requirements, Tyvek™ clothing, masks, head covers and footwear, while maintaining stringent husbandry procedures. Solid and liquid waste from each suite was either incinerated or collected and denatured by alkaline digestion.

Muntjac Dam Inoculations and CWD Status Monitoring {#s2d}
--------------------------------------------------

Muntjac dams were dosed with 1.0 gram brain orally (PO) or 1.0 gram total brain PO/subcutaneously (SC) (0.5 gr PO/0.5 gr SC) sourced from a CWD positive white-tailed deer used in previous studies [@pone.0071844-Mathiason1], [@pone.0071844-Mathiason3]. Negative control muntjac dams were dosed in the same manner with 1.0 gram brain sourced from naïve white-tailed deer used in previous studies [@pone.0071844-Mathiason1]. Dams were monitored for infection by detection of the protease-resistant prion protein associated with CWD (PrP^CWD^), as detected by immunohistochemistry (IHC) of serial tonsil and RAMALT biopsies collected at monthly intervals.

Breeding {#s2e}
--------

CWD and mock-infected muntjac dams were mated with intact naïve male muntjac to assess the effects of early and late CWD infection on vertical/maternal transmission. Males typically remained with the females for the duration of the pregnancy until the females were isolated prior to parturition. Ultrasounds were performed on all bred muntjac dams at two-week intervals to estimate gestational stage.

Muntjac CWD Cervid Transgenic (CerTgPrP) Mouse Bioassay {#s2f}
-------------------------------------------------------

Two cohorts of transgenic mice expressing the cervid prion protein (CerTgPrP) (54) (n = 9/cohort) were intracranially (IC)-inoculated with either 30 µl 0.1% muntjac CWD pool or naïve muntjac obex. The muntjac CWD pool consists of the obex region harvested from two CWD-inoculated dams (\#11 and \#15) at terminal disease (24 and 26 months post inoculation respectively). Naïve muntjac obex was pooled from two mock-inoculated muntjac (\#62 and \#64) serving as negative controls. Mice were monitored daily for clinical disease and terminal brain tissues were analyzed for infection by detection of PrP^CWD^ by IHC and Western blot.

Study Design {#s2g}
------------

### Dam cohorts {#s2g1}

Once the muntjac dams were determined to be CWD lymphoid biopsy positive, two cohorts of CWD-infected muntjac dams and one cohort of negative control muntjac dams were established ([Table 1](#pone-0071844-t001){ref-type="table"}). Cohort 1: dams bred during early stage CWD infection (\< ½ time to dam terminal TSE disease), Cohort 2: dams bred during late stage CWD infection (\> ½ time to dam terminal TSE disease) and Cohort 3: dams bred as mock-infected negative muntjac.

10.1371/journal.pone.0071844.t001

###### Study design to investigate CWD vertical/maternal transmission.

![](pone.0071844.t001){#pone-0071844-t001-1}

  Offspring cohort              Dam's CWD status                 Dam \#                             Offspring \#              Dam's clinical disease stage (cohort)   Offspring gestational stage
  ---------------------------- ------------------ ------------------------------------- ------------------------------------ --------------------------------------- -----------------------------
  **Full term viable**              Positive       11[\*](#nt101){ref-type="table-fn"}   24[2](#nt109){ref-type="table-fn"}                 Late (2)                           Full term
                                                                   45                    53[1](#nt108){ref-type="table-fn"}                 Late (2)                           Full term
                                                                   46                    55[1](#nt108){ref-type="table-fn"}                 Early (1)                          Full term
                                    Negative                       16                    20[1](#nt108){ref-type="table-fn"}                  NCD (3)                           Full term
                                                                   16                    22[2](#nt109){ref-type="table-fn"}                  NCD (3)                           Full term
                                                                   19                    21[1](#nt108){ref-type="table-fn"}                  NCD (3)                           Full term
                                                                   19                    26[2](#nt109){ref-type="table-fn"}                  NCD (3)                           Full term
  **Full term nonviable**           Positive       11[\*](#nt101){ref-type="table-fn"}   23[1](#nt108){ref-type="table-fn"}                 Early (1)                          Full term
                                                                   50                    54[1](#nt108){ref-type="table-fn"}                 Early (1)                          Full term
                                                                   15                    25[1](#nt108){ref-type="table-fn"}                 Late (2)                           Full term
                                                                   47                    51[1](#nt108){ref-type="table-fn"}                 Late (2)                           Full term
                                                                   44                    52[1](#nt108){ref-type="table-fn"}                 Late (2)                     Full term died 10 dpb
                                                                   43                    56[1](#nt108){ref-type="table-fn"}                 Late (2)                     Full term died 2 dpb
                                    Negative                       16                    27[3](#nt110){ref-type="table-fn"}                  NCD (3)                     Full term died 5 dpb
  ***In utero*** **harvest**        Positive                       47                    57[2](#nt109){ref-type="table-fn"}                 Late (2)                        Late gestation
                                                                   45                    58[2](#nt109){ref-type="table-fn"}                 Late (2)                        Late gestation
                                                                   50                    59[2](#nt109){ref-type="table-fn"}                 Late (2)                        Early gestation
                                    Negative                       64                    80[1](#nt108){ref-type="table-fn"}                  NCD (3)                        Early gestation

Dam inoculated orally (PO) only. All other dams inoculated PO and subcutaneously (SC).

Late = \> ½ time to dam terminal TSE disease.

Early = \< ½ time to dam terminal TSE disease.

Late gestation = \>3.5 months gestation.

Early gestation = \<3.5 months gestation.

NCD = No clinical disease.

dpb = days post birth.

Dam's first conception.

Dam's second conception.

Dam's third conception.

### Offspring cohort -- full-term viable {#s2g2}

Three viable offspring were born to CWD-infected dams ([Table 1](#pone-0071844-t001){ref-type="table"}). Two (\#24 and \#53) were born to CWD-infected dams that conceived during the late stage of infection, while the third (\#55) was born to a CWD-infected dam that conceived during the early stage of infection. Two viable offspring (\#20 and \#26) were born to mock-infected dams and served as negative viable controls. Offspring were left with their mothers for 55 to 150 days post birth (dpb).

### Offspring cohort -- full-term nonviable {#s2g3}

Six full-term nonviable offspring were born to CWD-infected dams ([Table 1](#pone-0071844-t001){ref-type="table"}). Two (\#23 and \#54) were born to dams that conceived during the early stage of CWD-infection; the other four (\#25, \#51, \#52, \#56) were born to CWD-infected dams that conceived during late stage infection. Offspring \#52 and \#56 were born alive, but died at 10 and 2 dpb, respectively. Three offspring born to mock-infected dams served as negative controls. One nonviable negative control offspring (\#27) was born and died at 5 dpb, and the other two negative controls were euthanized at 20 and 26 months post birth (mpb) (\#21 and \#22).

### Offspring cohort -- harvested in utero {#s2g4}

Three *in utero* derived fetuses (\#57, \#58, \#59) were harvested from late stage CWD-infected dams euthanized due to terminal clinical disease ([Table 1](#pone-0071844-t001){ref-type="table"}). Fetal tissues were harvested during first (\#59), second (\#58) and third (\#57) trimester based on breeding dates and fetal measurements. Fetuses were classified as early gestation (\<3.5 months gestation \[\#59\]) or late gestation (\>3.5 months gestation \[\#58 and \#57\]). One late stage mock-infected *in utero* harvested fetus (\#80) served as negative control.

Monitoring and Sample Collection {#s2h}
--------------------------------

### Longitudinal monitoring of viable offspring {#s2h1}

Viable muntjac offspring were monitored for CWD infection by IHC detection of PrP^CWD^ in serial RAMALT and tonsilar biopsies. Biopsies were collected at birth and thereafter at weekly/monthly intervals using animal specific blades, forceps and biopsy instruments.

### Terminal collections {#s2h2}

Maternal bodily fluids and excreta (blood, saliva, urine, feces), pregnancy related fluids (amniotic and allantoic) and tissues from each dam and fetus (*in utero* harvest) or nonviable offspring muntjac were harvested, fixed and/or frozen for the detection of the PrP^CWD^. Single-use, animal and tissue-specific blades and forceps were used to harvest each tissue.

Western Blotting {#s2i}
----------------

Tissue homogenates were prepared from the obex region of the medulla oblongata at 10% (w/v) in NP-40 buffer (10 mM Tris-HCl buffer pH 7.5, 0.5% NP-40, 0.5% sodium deoxycholate) in a FastPrep FP120 cell disrupter (Qbiogene) with one 45 second cycle at a speed setting of 6.5, then cooled on ice. Homogenates were mixed with proteinase K (PK) (Invitrogen) at a final concentration of 20 µg/ml and incubated at 37°C for 30 minutes with shaking. Samples were mixed with Reducing Agent (10X)/LDS Sample Buffer (4X) (Invitrogen) at a final concentration of 1X, heated to 95°C for 5 minutes, then run through a NuPAGE 10% Bis-Tris gel at 100 volts for 2.5 hours. Proteins were transferred to a polyvinylidene fluoride (PVDF) membrane at 100 volts for 1 hour in transfer buffer (0.025 M Trizma base, 0.2 M glycine, 20% methanol, pH 8.3). The membrane was loaded into a pre-wetted SNAP i.d. blot holder (Millipore) then placed in the SNAP i.d. system (Millipore). Blocking buffer (Blocker Casein in TBS \[Thermo Scientific\] with 0.1% Tween 20) was added to the blot holder for 10 minutes followed by vacuum removal. Primary antibody BAR224 (Cayman Chemical) conjugated to horseradish peroxidase (HRP) was diluted in blocking buffer to 0.2 µg/ml, added to the blot holder, incubated for 12 minutes, then vacuumed through the membrane. The membrane was washed three times with 30 ml volumes of wash buffer (50% Blocker Casein in TBS, 50% 1X Tris-buffered saline (TBS), 0.1% Tween 20) with continuous vacuum, then developed with ECL Plus Western Blotting Detection Reagents (GE) and viewed on a Luminescent Image Analyzer LAS-3000 (Fujifilm).

Immunohistochemistry {#s2j}
--------------------

Tissues were fixed in 10% neutral buffered formalin or paraformaldehyde/lysine/periodate (PLP) for 5 days or 2 days respectively and stored in 60% ethanol. Tissues were treated for 1 hour with formic acid, rinsed with tap water, embedded in paraffin, and 6 µm sections were placed on positively charged slides. Slides were placed in a 65°C incubator for 1 hour to melt the paraffin, run through a series of xylene and graded ethanol baths to deparaffinize and rehydrate the tissue sections, PK digested (20 mg/ml) at 37°C in 1X TBS for 15 minutes, washed for 10 minutes in TNT buffer (0.1 M Tris-HCl, pH 7.5, 0.15 M NaCl, and 0.05% Tween 20), and subjected to heat-induced epitope retrieval in the 2100-Retriever (Prestige Medical) in sodium citrate buffer (0.01 M sodium citrate, 0.05% Tween 20, pH 6.0). Prions were labeled with primary antibody BAR224 (Cayman Chemical) at 1 µg/ml and Envision+ anti-mouse HRP labeled polymer (Dako). Slides were incubated with AEC Substrate-Chromagen (Dako), counterstained with hematoxylin and bluing reagent (0.1% sodium bicarbonate), and coverslipped with an aqueous mounting medium (Vector Laboratories).

Serial Protein Misfolding Cyclic Amplification (sPMCA) {#s2k}
------------------------------------------------------

Fetal tissues were analyzed by sPMCA using previously published methods [@pone.0071844-Haley1], [@pone.0071844-Denkers1] incorporating the following modifications. One to ten percent tissue homogenates were prepared in 1% TX-100/0.1 M PBS with 2.5 mm ceramic (Zirconium/Silica) beads in a FastPrep FP120 cell disrupter (Qbiogene) with one 45 second cycle at a speed setting of 6.5, then cooled on ice. The initial round of sPMCA incorporated 20 µl of tissue homogenate sample plus 80 µl normal Tg(cerPrP) [@pone.0071844-Browning1] brain homogenate (NBH) placed in individual PCR tubes (USA Scientific, St. Louis, MO) containing two 2.38 mm and three 3.15 mm Teflon beads (McMaster-Carr). The PCR tubes were sealed with parafilm, vortexed for 6 seconds and subjected to one round of PMCA. Each round of PMCA is equal to 288 cycles of sonication (Misonix, Farmingdale, NY) (10 seconds separated by 5 minute incubations) at 37°C over 24 hours. Five rounds of sPMCA were completed in duplicate per tissue by transferring 20 µl aliquots of the previous round into 60 µl fresh NBH (1∶3 dilution). The fifth round of sPMCA was analyzed by Western blot. The samples were maintained in a blinded format with identities released post Western blot analysis.

Results {#s3}
=======

PRNP Genotypes {#s3a}
--------------

For this study the *PRNP* open reading frame was sequenced in full for all muntjac deer (8 dams and 12 offspring). Reeves' muntjac *PRNP,* as in other cervids, encodes Gln (codon 95), Gly (codon 96), Met (codon 132) and Ser (codon 225) in positions that are known to modulate susceptibility and incubation period of CWD. No polymorphisms were detected in our 20 study animals, and the sequence differed uniquely in codon 98 between *Muntiacus reevesi* (Ser, Genbank accession no. KC788406) and deer from other genera, e.g. mule deer (Thr, *Odocoileus hemionus*, Genbank AY228473) and white-tailed deer (Thr, *Odocoileus virginanus*, Genbank AY286008). Serine at codon 98 is common in ruminants such as cattle, sheep and goats but can also be found substituted by glycine, alanine or threonine in other species.

Muntjac CWD CerTgPrP Mouse Bioassay {#s3b}
-----------------------------------

Nine of nine muntjac CWD-inoculated mice developed clinical disease including weight loss, hind limb paralysis, stiff tail, and ataxia at 200±29 dpi. CWD detection was confirmed (9/9) and compared to mock-inoculated CerTgPrP mice and white-tailed deer CWD by Western blot analysis ([Figure 1](#pone-0071844-g001){ref-type="fig"}).

![PrP^CWD^ detection in CerTgPrP mice inoculated with muntjac CWD.\
Western blot detection of PrP^CWD^ in brains of CerTgPrP mice (n = 9) IC-inoculated with obex from a CWD+ white-tailed deer (lane 2) or CWD+ muntjac (lanes 4--12) following PK digestion. Complete PK digestion of PrP^C^ is shown in a mouse inoculated with negative deer obex (lane 2).](pone.0071844.g001){#pone-0071844-g001}

Detection of PrP^CWD^ in Muntjac Dams {#s3c}
-------------------------------------

Eight of eight CWD-inoculated muntjac dams were immunohistochemistry (IHC) PrP^CWD^ positive in tonsil and/or recto-anal mucosa associated lymphoid tissue (RAMALT) biopsies as early as 4 months pi by IHC ([Figure 2A](#pone-0071844-g002){ref-type="fig"}). All dams were confirmed CWD positive by terminal obex IHC and Western blot ([Figure 2B](#pone-0071844-g002){ref-type="fig"}).

![PrP^CWD^ detection in CWD-inoculated dams.\
(A) IHC PrP^CWD^ is demonstrated (red deposits) in a tonsilar lymphoid biopsy collected at 4 mpi (A3) and in the obex of a terminal TSE diseased dam at 23 mpi (A1). Absence of red deposits is shown in negative control tonsil (A4) and obex (A2). Picture objective is 20X (scale bar = 200 µm). (B) Western blot detection of PrP^CWD^ in obex tissue of a CWD-inoculated dam at 23 mpi (B lane 5) following PK digestion. Complete PK digestion of PrP^C^ is shown in negative control deer obex (B lane 3). PrP^CWD^ detection is demonstrated in CWD positive control deer obex (B lane 2).](pone.0071844.g002){#pone-0071844-g002}

Clinical Disease Progression of CWD-positive Muntjac Dams {#s3d}
---------------------------------------------------------

CWD PO and PO/SC-inoculated dams developed terminal disease including progressive weight and body muscle mass loss, lethargy and ataxia over the course of 18--24 months pi. No appreciable difference was observed between PO or PO/SC inoculates regarding time to biopsy positivity, clinical disease presentation and progression, or the ability to maintain pregnancy. These dams were able to breed and maintain one (4 of 8) or two (4 of 8) full term pregnancies before succumbing to disease. Dams that gave birth to full-term viable and full-term nonviable fawns were able to deliver their offspring naturally without the aid of cesarean section.

Detection of PrP^CWD^ in Muntjac Offspring ([Table 2](#pone-0071844-t002){ref-type="table"}, [Figures 3](#pone-0071844-g003){ref-type="fig"}, [4](#pone-0071844-g004){ref-type="fig"}, [5](#pone-0071844-g005){ref-type="fig"}) {#s3e}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

### Full-term viable offspring {#s3e1}

PrP^CWD^ was first demonstrated by IHC in the lymphoid tonsil biopsy of offspring \#24 at 40 dpb and the RAMALT biopsy at 102 dpb ([Figure 3](#pone-0071844-g003){ref-type="fig"}). Offspring \#53 and \#55 were IHC-PrP^CWD^ tonsil/RAMALT biopsy positive at 504/504 dpb and 465/386 dpb respectively ([Figure 3](#pone-0071844-g003){ref-type="fig"}). Amplifiable CWD prions were first detected in tonsil or RAMALT biopsy by 5 rounds of sPMCA in offspring \#24 at 376 dpb, \#53 at 107 dpb and \#55 at 386 dpb ([Figures 4](#pone-0071844-g004){ref-type="fig"} and [5](#pone-0071844-g005){ref-type="fig"}). Lymphoid tonsil and RAMALT biopsies harvested from offspring of mock-inoculated controls (\#20, \#21, \#22, \#26) remained IHC and sPMCA PrP^CWD^ negative.

![IHC PrP^CWD^ detection in viable muntjac fawns born to CWD+ dams.\
PrP^CWD^ is demonstrated (red deposits) in tonsilar biopsies collected at 40 days post birth (dpb, A), 465 dpb (C) and 504 dpb (E) and RAMALT biopsies collected at 103 dpb (B), 386 dpb (D) and 504 dpb (F) and confirmed in the terminal tissues of 1 fawn (G, H, I). Absence of PrP^CWD^ is shown in negative control tissues (J, K, L). Picture objective is 40X (scale bar = 100 µm) with insets at 20X (scale bar = 200 µm).](pone.0071844.g003){#pone-0071844-g003}

![Amplifiable CWD prions detected in muntjac dam and fetal tissues.\
All panels show representative Western blot results after 5 rounds of sPMCA. Samples considered CWD positive are denoted with an asterisk (\*). (A-H) Complete PK digestion of PrP^C^ is shown in negative deer brain controls (-C) without and with PMCA. PrP^CWD^ detection is shown in positive deer controls (+C) following PK digestion without and with PMCA. Tissue abbreviations are defined as follows: C = control, MED = mediastinal lymph node, PAR = parotid lymph node, POP = popliteal lymph node, MES = mesenteric lymph node, PLA = placenta, HLN = hepatic lymph node, TE = third eyelid, MAN = mandibular lymph node, TON = tonsil, ILN = ileocecocolic lymph node, RAM = recto-anal mucosa associated lymphoid tissue, SP = spleen, RLN = retropharyngeal lymph node, IL = ileum, TLN = tracheobronchial lymph node, SLN = sublumbar lymph node, OB = obex, MAM = mammary lymph node, CA = caruncle.](pone.0071844.g004){#pone-0071844-g004}

![CWD detection in tissues harvested from offspring of CWD+ dams.\
Tonsilar and RAMALT biopsies harvested from viable (v) offspring were analyzed for PrP^CWD^ by IHC. All tissues from nonviable (NV) and *in utero* (IU) derived tissues were analyzed for amplifiable CWD prions by 5 rounds of sPMCA. Tissues from mock-inoculated offspring were IHC and or sPMCA negative.](pone.0071844.g005){#pone-0071844-g005}

### Full-term nonviable offspring {#s3e2}

Amplifiable CWD prions were detected by sPMCA in 10 of 16 tissues tested from 6 full-term nonviable offspring (\#23, \#54, \#25, \#51, \#52, \#54, \#56) born to CWD-infected dams ([Table 2](#pone-0071844-t002){ref-type="table"}, [Figures 4](#pone-0071844-g004){ref-type="fig"} and [5](#pone-0071844-g005){ref-type="fig"}). All six nonviable offspring had at least two tissues containing amplifiable CWD prions-- including obex, placenta, spleen, tonsil, RAMALT and popliteal, mammary, retropharyngeal, mesenteric and ileocecocolic lymph nodes. In two of the nonviable offspring (\#52 and \#56) that were born alive but died at 10 and 2 dpb, amplifiable CWD prions were demonstrated in retropharyngeal and mesenteric lymph node, spleen and RAMALT ([Figures 4](#pone-0071844-g004){ref-type="fig"} and [5](#pone-0071844-g005){ref-type="fig"}). Negative control tissues (\#27) remained negative during 5 rounds of sPMCA.

10.1371/journal.pone.0071844.t002

###### IHC and PMCA CWD detection in offspring born to mock and CWD-infected muntjac.

![](pone.0071844.t002){#pone-0071844-t002-2}

  Offspring cohort              Dam's CWD status   Dam \#   Offspring \#/status    Offspring IHC           Offspring PMCA
  ---------------------------- ------------------ -------- --------------------- ----------------- -------------------------------
  **Full term viable**              Positive         11     24/cl, fair 58 mpb    40\*/102^∧^dpb              376^∧^dpb
                                                     45     53/cl, term 45 mpb      504\*^∧^dpb            107\*/301^∧^dpb
                                                     46     55/cl, term 40 mpb    465\*/386^∧^dpb            386\*^∧^dpb
                                    Negative         16             20               Negative                 Negative
                                                     16             22                  ND                    Negative
                                                     19             21                  ND                    Negative
                                                     19             26               Negative                 Negative
  **Full term nonviable**           Positive         11             23                  ND           Pla, RLN, Sp, Ton, Pop, Mam
                                                     50             54                  ND                     Ob, Mes
                                                     15             25                  ND                     Ob, Pop
                                                     47             51                  ND             Ob, Pla, Mes, Iln, Pop
                                                     44       52/died 10 dpb            ND                 Mes, Sp, RAMALT
                                                     43        56/died 2 dpb            ND                    RLN, Mes
                                    Negative         16        27/died 5 dpb            ND                    Negative
  ***In utero*** **harvest**        Positive         47             57                  ND                 Ob, Pla, RAMALT
                                                     45             58                  ND          Pla, Mes, Iln, I, RAMALT, Par
                                                     50             59                  ND                       Pla
                                    Negative         64             80                  ND                    Negative

**cl** = clinical; **fair** = health condition; **\*** = tonsil biopsy; ^∧^ = RAMALT biopsy; **term** = terminated due to clinical TSE disease; **ND** = not done; **Pla** = placenta; **RLN** = retropharyngeal lymph node; **Sp** = spleen; **Ton** = tonsil; **Pop** = popliteal lymph node; **Mam** = mammary lymph node; **Ob** = obex; **Mes** = mesenteric lymph node; **Iln** = Ileocecocolic lymph node; **RAMALT** =  recto-anal mucosa associated lymphoid tissue; **I** = ileum; **Par** = parotid lymph node.

### In utero harvested fetal tissues {#s3e3}

Amplifiable CWD prions were detected by sPMCA in 6 of 10 tissues tested from 3 *in utero* harvested fetuses (\#57, \#58, \#59) ([Table 2](#pone-0071844-t002){ref-type="table"}, [Figures 4](#pone-0071844-g004){ref-type="fig"} and [5](#pone-0071844-g005){ref-type="fig"}). In all three (100%) fetuses at least one positive tissue-- including obex, placenta, ileum, RAMALT, mesenteric and parotid lymph nodes ([Figures 4](#pone-0071844-g004){ref-type="fig"} and [5](#pone-0071844-g005){ref-type="fig"}) was demonstrated. *In utero* harvested negative control tissues (\#80) remained negative during 5 rounds of sPMCA.

Clinical Disease Progression in CWD-positive Muntjac Offspring {#s3f}
--------------------------------------------------------------

All three viable offspring born to CWD-infected dams developed clinical disease. Fawn \#24 exhibited weight loss, muscle wasting and an unthrifty appearance at 28 mpb. Clinical disease progression in this CWD-infected fawn plateaued at 30 mpb and has not yet changed (currently at 50 mpb). Viable fawns \#53 and \#55 developed terminal disease including \>20% weight loss, body mass loss, excessive salivation, rumen regurgitation and ataxia, and were euthanized at 34 and 31 mpb, respectively.

Discussion {#s4}
==========

Reeves' Muntjac Deer are Susceptible to CWD Infection {#s4a}
-----------------------------------------------------

CWD, the only prion disease in a wildlife population, exhibits high transmission rates among cervids in their natural environment. We and others (A. Young and R. Bessen, unpublished) demonstrated that PO and PO/SQ inoculated Reeves' muntjac deer are susceptible to CWD infection, become lymphoid biopsy CWD-positive as early as 4 mpi and develop terminal disease in 18--24 months. Similar findings have been reported for other naturally and experimentally CWD-infected cervid species [@pone.0071844-Mathiason1], [@pone.0071844-Miller1], [@pone.0071844-Miller2], [@pone.0071844-Mathiason4]. In further support of the Reeves' muntjac as a suitable host/model for CWD studies our CerTgPrP bioassay confirms that clinical disease presentation and time to terminal disease of muntjac CWD-inoculated mice is comparable to that of mule deer and elk-inoculated CerTgPrP mice (160--230 dpi) [@pone.0071844-Browning1]. In this study we have demonstrated that a CWD susceptible deer species is able to maintain full term pregnancies throughout the course of disease. Our observations are congruent with those of Blanchong et al. [@pone.0071844-Blanchong1] in white-tailed deer. We have shown that muntjac are a useful model for studying CWD.

Transmission of CWD to Offspring {#s4b}
--------------------------------

Maternally-associated transmission of prion diseases has been suggested for BSE [@pone.0071844-BrugrePicoux1]--[@pone.0071844-Castilla1], FSE [@pone.0071844-Bencsik1], CJD [@pone.0071844-Tamai1] and scrapie [@pone.0071844-Dickinson1], [@pone.0071844-Hadlow1], [@pone.0071844-Eklund1]. For decades it has been known that scrapie incidence increases during the lambing season [@pone.0071844-Caplazi1], [@pone.0071844-Dickinson1]--[@pone.0071844-Brotherston1]. As assay sensitivity improved, PrP^RES^ was detected in placentomes, placental and fetal tissues harvested from sheep naturally infected with scrapie [@pone.0071844-Tuo2], [@pone.0071844-Garza1]. Also, the presence of CJD prions was demonstrated in brain, placenta and umbilical cord blood collected from an infected woman using mouse bioassays [@pone.0071844-Tamai1]. In this study, using both conventional assays and assays with heightened sensitivity, we have demonstrated for the first time CWD transmission from infected mothers to full term viable and nonviable offspring, as well as to *in utero* fetuses.

### Viable offspring {#s4b1}

The generation of a cohort of offspring that carry and potentially shed infectious prions to the environment and/or one another is of particular interest due to the efficiency of CWD transmission in the native host population. In this study we have demonstrated mother to offspring transmission and disease progression to a viable cohort of offspring that were born to CWD-infected dams. This is the earliest demonstration of TSE IHC tonsil biopsy positivity. Of interest is that all three fawns surpassed the time when terminal disease is typically observed (18--24 months) in cervid species [@pone.0071844-Miller1], [@pone.0071844-Williams1], [@pone.0071844-Williams2]. It is possible that these fawns were exposed to a very low dose of maternal infectious prions or that a unique strain is associated with mother to offspring transmission. The single remaining CWD positive viable offspring will continue to be monitored for clinical disease progression, development of blood prionemia, as well as ability to procreate and transmit disease to its own offspring.

### Nonviable offspring {#s4b2}

In our study, we were able to closely monitor breeding, pregnancy and delivery. We observed a 60% decrease in full-term viable offspring born to CWD-infected dams when compared to naïve controls. We have demonstrated that 100% of these nonviable offspring have at least two tissues containing amplifiable CWD prions. In addition, we have demonstrated amplifiable CWD prions in tissues harvested from offspring that were born alive but failed to thrive and died a few days post birth, suggesting *in utero* exposure.

Transmission of CWD *in utero* {#s4c}
------------------------------

Assessing prion infection *in utero* has been challenging due to limitations in assay sensitivity. Recently, Garza et al. [@pone.0071844-Garza1] demonstrated amplifiable prions in fetal and maternal tissues harvested from sheep naturally infected with scrapie. Here, using the same highly sensitive PMCA assay, we have analyzed early and late gestational stage fetal tissues harvested from CWD-infected dams in the early (\< ½ the time to terminal CWD) or late (\> ½ the time to terminal disease) stage of CWD infection and found that 100% of *in utero* harvested fetuses contain amplifiable CWD prions. Detection of PrP^CWD^ in early gestational fetal tissues indicates the existence of a mechanism for vertical prion transmission.

Potential Mechanisms for Maternal to Fetal Transmission {#s4d}
-------------------------------------------------------

Infected ewes harbor scrapie prions in mammary tissues [@pone.0071844-Ligios1] and can transmit infection to lambs that ingest their milk [@pone.0071844-Konold1]. Tuo et al. [@pone.0071844-Tuo2], Andreoletti et al. [@pone.0071844-Androletti1] and Tamai et al. [@pone.0071844-Tamai1] have provided additional evidence for vertical transmission by demonstrating prions in maternal and fetal tissues of sheep and humans. Of interest is the path infectious prions take from mother to offspring. Since a number of studies proved that infectious prions are present in the blood of symptomatic and asymptomatic hosts [@pone.0071844-Wroe1], [@pone.0071844-Houston1]--[@pone.0071844-Hunter1], [@pone.0071844-Terry1]--[@pone.0071844-Peden2], it is possible that infectious prions are trafficked via maternal blood to fetal trophectoderm, where they are taken up by fetal-derived multinucleated trophoblast cells -- cells with mobility and phagocytic properties [@pone.0071844-Wooding1]--[@pone.0071844-Myagkaya1] at the feto-maternal interface.

In addition, during gestation, to further the development of the fetal respiratory and digestive systems, the fetus recirculates approximately 500 ml of amniotic fluid daily via oronasal ingestion [@pone.0071844-Harding1]--[@pone.0071844-Ross1]. Amniotic fluid consists of maternal plasma and/or fetal urine, depending upon gestational stage (primarily maternal plasma in early gestation vs. mostly fetal urine in late gestation) [@pone.0071844-Cho1]. If either the amniotic fluid or the fetus contains infectious prions, susceptible fetal mucosal surfaces could be continuously bathed in -- and thus exposed to -- infectious prions throughout gestation.

Implications Associated with Transmission of CWD to Offspring {#s4e}
-------------------------------------------------------------

The facile transmission of CWD seen in herds of free ranging and captive cervids has led to questions regarding the modes of transmission. While direct contact with infected cervids, as well as indirect contact with infectious bodily fluids and contaminated environments are suspected to account for much of this transmission, a third path of transmission, the one from mother to offspring, may be underappreciated. PrP^CWD^ placental accumulation and CWD *in utero* acquirement would help explain the surprisingly high rates of CWD among cervids. Moreover, CWD positive nonviable offspring carcasses 1) would contribute to environmental prion contamination [@pone.0071844-Miller3] and 2) would be available for consumption by scavenger species, thus increasing the potential for cross-species transmission [@pone.0071844-Mathiason3], [@pone.0071844-Jennelle1], [@pone.0071844-Miller4]. Viable offspring may spread disease by 1) direct cervid-to-cervid contact, 2) multigenerational mother to offspring transmission, as well as 3) shedding infectious prions in bodily secretions (urine, feces, saliva, blood) during their entire lifespan.

Here, in an experimental model of CWD, we have demonstrated the transmission of infectious prions from clinical and subclinical mothers to full-term viable, nonviable and *in utero* harvested offspring, revealing that the transmission of TSEs from mother to offspring can occur and may be underestimated for all prion diseases.
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